Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene. Boileau M, Descarpentries C, Delzenne G, Trentesaux V, et al. Melanoma Res 2023 Mar 3. doi: 10.1097/CMR.0000000000000882.

Read + Share

Amedeo Smart

Independent Medical Education

Boileau M, Descarpentries C, Delzenne G, Trentesaux V, et al. Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene. Melanoma Res 2023 Mar 3. doi: 10.1097/CMR.0000000000000882.
PMID: 36866640